First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2009-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2009.05.107PMID 19515561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, Synthesis, and Biological Evaluation of Levoglucosenone‐Derived Ras Activation Inhibitors

  2009cited by this paper
• Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts

  2009cited by this paper
• Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE.

  2007cited by this paper
• GEFs and GAPs: critical elements in the control of small G proteins.

  2007cited by this paper
• Glucose‐Derived Ras Pathway Inhibitors: Evidence of Ras–Ligand Binding and Ras–GEF (Cdc25) Interaction Inhibition

  2007cited by this paper
• Transformation efficiency of RasQ61 mutants linked to structural features of the switch regions in the presence of Raf.

  2007cited by this paper
• Sugar-derived ras inhibitors : Group epitope mapping by NMR spectroscopy and biological evaluation

  2006cited by this paper
• Combining docking and molecular dynamic simulations in drug design

  2006cited by this paper
• Ras-dependent carbon metabolism and transformation in mouse fibroblasts

  2006cited by this paper
• Colchicine glycorandomization influences cytotoxicity and mechanism of action.

  2006cited by this paper
• Design, Synthesis and Biological Evaluation of Sugar‐Derived Ras Inhibitors

  2005cited by this paper
• Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.

  2005cited by this paper
• Mechanism of the guanine nucleotide exchange reaction of Ras GTPase--evidence for a GTP/GDP displacement model.

  2005cited by this paper
• Design and Characterization of a New Class of Inhibitors of Ras Activation

  2004cited by this paper
• Chemoselective ligation in glycochemistry.

  2004cited by this paper
• Targeting RAS signalling pathways in cancer therapy

  2003cited by this paper
• Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues.

  2002cited by this paper
• Ras-A Molecular Switch Involved in Tumor Formation.

  2000cited by this paper
• Guanosine triphosphatase stimulation of oncogenic Ras mutants.

  1999cited by this paper
• Interaction of a novel GDP exchange inhibitor with the Ras protein.

  1998cited by this paper
• Increasing Complexity of the Ras Signaling Pathway*

  1998cited by this paper
• GTP analogue hydrolysis by the Gs protein: implication for the role of catalytic glutamine in the GTPase reaction

  1998cited by this paper
• The structural basis of the activation of Ras by Sos

  1998cited by this paper
• Chemo- and stereoselective glycosylation of hydroxylamino derivatives: A versatile approach to glycoconjugates

  1998cited by this paper
• Rescue of a mutant G-protein by substrate-assisted catalysis.

  1997cited by this paper
• Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex.

  1997cited by this paper
• Analysis of intrinsic and CDC25-stimulated guanine nucleotide exchange of p21ras-nucleotide complexes by fluorescence measurements.

  1995cited by this paper
• Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.

  1994cited by this paper
• Function and regulation of ras.

  1993cited by this paper
• ras GTPase activating protein: signal transmitter and signal terminator.

  1989cited by this paper
• Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation

  1989cited by this paper
• ras genes.

  1987cited by this paper

• A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C).

  2023cites this paper
• Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies

  2022cites this paper
• KRAS G12C fragment screening renders new binding pockets

  2021cites this paper
• The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells

  2021cites this paper
• Targeting the Small GTPase Superfamily through Their Regulatory Proteins

  2020cites this paper
• Targeting der kleinen GTPasen über ihre regulatorischen Proteine

  2020cites this paper
• Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives

  2020cites this paper
• Targeting Bacterial Biofilm: A New LecA Multivalent Ligand with Inhibitory Activity

  2019cites this paper
• Drugging the Small GTPase Pathways in Cancer Treatment: Promises and Challenges

  2019cites this paper
• Natural Compounds in Cancer Prevention: Effects of Coffee Extracts and Their Main Polyphenolic Component, 5-O-Caffeoylquinic Acid, on Oncogenic Ras Proteins.

  2017cites this paper
• The small GTPases Ras and Rheb studied by multidimensional NMR spectroscopy: structure and function

  2017influential citation
• Glyco-functionalized dinuclear rhenium(i) complexes for cell imaging.

  2017cites this paper
• Search for Inhibitors of Ras-Driven Cancers

  2017cites this paper
• Targeting the KRAS Pathway in Non-Small Cell Lung Cancer.

  2016cites this paper
• Sustainable Synthesis of Oximes, Hydrazones, and Thiosemicarbazones under Mild Organocatalyzed Reaction Conditions.

  2016cites this paper
• The Bisphenol A analogue Bisphenol S binds to K‐Ras4B – implications for ‘BPA‐free’ plastics

  2016cites this paper
• 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells.

  2016cites this paper
• Targeting oncogenic signaling proteins : new insights using a FRET-based chemical biology approach

  2016cites this paper
• Pharmacological modulation of oncogenic Ras by natural products and their derivatives: Renewed hope in the discovery of novel anti-Ras drugs.

  2016cites this paper
• From Unspecific Quenching to Specific Signaling: Functional GTPase Assays Utilizing Quenching Resonance Energy Transfer (QRET) Technology

  2015cites this paper
• Direkte Modulation von Aktivität und Funktion kleiner GTPasen

  2015cites this paper
• Direct Modulation of Small GTPase Activity and Function.

  2015cites this paper
• A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non–Small Cell Lung Cancer

  2014cites this paper
• Neoglycosylation and neoglycorandomization: Enabling tools for the discovery of novel glycosylated bioactive probes and early stage leads.

  2014cites this paper
• Sequence-selective molecular recognition of the C-terminal CaaX-boxes of Rheb and related Ras-proteins by synthetic receptors.

  2014cites this paper
• Prospective Development of Small Molecule Targets to Oncogenic Ras Proteins

  2013cites this paper
• Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis.

  2013cites this paper
• Bisphenol A binds to Ras proteins and competes with guanine nucleotide exchange: implications for GTPase-selective antagonists.

  2013cites this paper
• Sugar-based inhibitors of Ras activation: biological activity and identification of Ras-inhibitor binding interface.

  2013cites this paper
• State 1(T) inhibitors of activated Ras.

  2013cites this paper
• Ras inhibition via direct Ras binding--is there a path forward?

  2012cites this paper
• Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity

  2012cites this paper
• Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells.

  2012influential citation
• Metal-bis(2-picolyl)amine complexes as state 1(T) inhibitors of activated Ras protein.

  2012cites this paper
• Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007 – present)

  2012cites this paper
• Metall‐Bis(2‐picolyl)amin‐Komplexe als Zustand‐1(T)‐Inhibitoren für aktiviertes Ras‐Protein

  2012cites this paper
• Analysis of binding site hot spots on the surface of Ras GTPase.

  2011cites this paper
• Carbohydrate-based bioactive compounds for medicinal chemistry applications.

  2011cites this paper
• Binding properties and biological characterization of new sugar-derived Ras ligands

  2011cites this paper